查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840701

青光眼手術器械市場（按手術方式、器械、最終用戶和分銷管道分類）－全球預測，2025-2032年

Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，青光眼手術器械市場將成長至 16.5457 億美元，複合年成長率為 7.23%。

關鍵市場統計數據
基準年 2024 9.4593億美元
預計年份：2025年 1,013,250,000 美元
預測年份 2032 1,654,570,000 美元
複合年成長率 (%) 7.23%

本書重點介紹青光眼手術器械領域中影響現代決策的臨床需求、器械類型、治療環境和通路。

青光眼仍然是導致不可逆性視力喪失的主要原因之一，而手術干預的臨床和商業性格局正因人口結構變化、監管政策發展和技術進步而迅速演變。在此背景下，一篇簡明扼要的介紹必須從臨床需求、器械創新和不斷演變的治療路徑的相互作用出發，闡述當前青光眼治療的現狀，這些因素都會影響臨床醫生的選擇和患者的治療結果。

從歷史上看，青光眼引流植入、小梁切除術和引流管植入等傳統手術方法一直是晚期青光眼手術治療的基石。同時，iStent、Kahook雙刃刀、Trabectome和XEN凝膠支架等微創手術方法拓展了早期青光眼以及白內障聯合青光眼手術的治療選擇。這些技術上的差異體現在器械類型上，包括雷射設備（分為氬雷射和選擇性雷射）；引流裝置（如Ahmed閥、Baerveldt植入和Molteno植入）；支架（如Hydrus微支架、iStent和XEN凝膠支架）；以及手術刀片（以Kahook雙刃刀和Trabectome平台為代表）。

門診手術中心、醫院和眼科診所的手術量、報銷趨勢和資本購置模式各不相同，這些因素都會影響其採購決策。分銷管道，包括直銷、線上銷售和第三方分銷商，進一步決定了醫療器材如何到達臨床醫生手中，以及製造商如何拓展其地理覆蓋範圍。這些因素有助於讀者建構理解以下章節的框架，這些章節將探討轉型變革、貿易政策影響、市場區隔細微差別、區域差異化因素、競爭策略以及為產業領導者提供的實用建議。

臨床重點、設備創新和採購管道轉變如何共同作用，重新定義青光眼手術的治療流程和競爭格局

青光眼手術器材領域正經歷一系列變革時期，這些變革正在重新定義臨床診療流程、採購慣例方式和創新重點。臨床上，人們明顯傾向於選擇併發症率更低、恢復時間更短且能與白內障手術相容的手術方式。因此，越來越多的臨床醫生正在權衡傳統手術方法（如青光眼引流植入植入、小梁切除術和引流管植入術）的長期有效性，以及微創手術（如iStent、Kahook雙刃刀、Trabectome和XEN凝膠支架）的便利性和良好的圍手術全期安全性。

隨著雷射技術分化為針對特定組織相互作用的氬雷射和選擇性模式，以及支架和分流器設計不斷迭代以提高生物相容性、流量控制和植入重複性，包括雷射設備、分流器、支架和手術刀片在內的器械細分正在從獨立的產品線轉向一體化的手術生態系統。

同時，供應和商業化模式也在不斷演變。門診手術中心、醫院和眼科診所各自擁有不同的獎勵機制，這影響著它們對直銷關係、線上採購或依賴第三方經銷商的選擇。監管監督和報銷政策的調整迫使製造商優先考慮實證醫學證據的開發和真實世界療效，從而加速那些能夠展現臨床和經濟價值的產品的推廣應用。總而言之，這些趨勢正在創造一個更加多元化的市場環境，多種方法並存，競爭日益以創新主導，而市場准入既需要臨床信譽，也需要穩健的市場進入策略。

2025年關稅實施後供應鏈的重組及其對製造和分銷網路營運、商業和採購的影響

2025年關稅的實施為眼科手術器械的全球供應鏈和定價策略帶來了新的複雜性。依賴跨境供應鏈採購關鍵零件和成品的製造商面臨投入成本的增加，這往往迫使他們重新評估其生產佈局、供應商合約和產品定價策略。為了應對這項挑戰，一些公司加快了關鍵生產流程的在地化進程或實現了供應商多元化，以降低風險；而另一些公司則選擇承受暫時的成本上漲，以維持市場進入和與臨床醫生的關係。

這些調整對分銷管道和終端用戶產生了連鎖反應。門診手術中心、醫院和眼科診所對價格的敏感度各不相同，取決於其報銷環境和採購模式。在直銷模式占主導地位的地區，製造商與採購團隊緊密合作，調整定價、捆綁銷售和服務協議。在第三方分銷仍然佔據重要地位的地區，經銷商不得不重新談判條款並管理庫存策略，以最大限度地減少利潤壓縮。

在營運方面，關稅的取消促使人們在評估醫療器材時重新專注於服務成本分析和總擁有成本 (TCO)。製造商更加重視營運效率、供應鏈透明度和售後支持，以支撐其定價策略。同時，政策環境凸顯了區域製造能力和靈活的分銷網路對於保持韌性並響應臨床醫生需求的重要性。整體而言，關稅主導的動態正在加速採取務實的短期措施來穩定供應，同時也促使醫療設備的生產和供應方式發生長期策略轉變。

主導的觀點將手術類型、醫療設備類別、醫療機構和分銷管道聯繫起來，揭示了目標明確的採用路徑和市場定位機會。

多維度的市場細分方法揭示了手術流程、器械、終端用戶和分銷管道等方面的明確成長要素和推廣障礙。依手術流程分類，市場可分為傳統手術和微創手術。由於青光眼引流植入、小梁切除術和引流管植入術等成熟技術的應用，傳統手術在治療晚期疾病方面仍具有臨床優勢。微創手術，包括iStent、Kahook Dual Blade、Trabectome和XEN Gel Stent等平台，因其良好的安全性和恢復性，擴大應用於輕度至中度青光眼患者以及白內障和青光眼聯合手術。

這些器械包括雷射裝置、引流管、支架和手術刀片。雷射技術分為氬雷射和選擇性雷射，分別針對不同的組織標靶和手術目標。引流管，例如Ahmed閥、Baerveldt植入和Molteno植入，仍是難治性青光眼治療的主要手段。支架技術，例如Hydrus微支架、iStent和XEN凝膠支架，代表了微創房水引流增強技術的創新，而手術刀片系統，例如Kahook雙刃刀和Trabectome，則支援具有不同學習曲線和術中操作特點的組織消融策略。

終端使用者細分凸顯了門診手術中心、醫院和眼科診所各自獨特的應用環境，這些環境與病例組合、資本規劃週期和醫療服務模式密切相關。銷售管道細分——包括直銷、線上銷售和第三方分銷商——闡明了製造商必須如何調整其銷售團隊策略、數位化通路和經銷商夥伴關係，以確保產品供應、臨床醫生培訓和售後支援。將產品創新與這些細分維度進行匹配，有助於相關人員確定臨床需求和商業機會的契合點，以及如何透過有針對性的證據產生來最有效地推動產品應用。

美洲、歐洲、中東和非洲以及亞太地區之間的戰略差異將決定商業化、證據和供應策略的差異性。

區域動態對醫療設備策略、報銷談判和商業化策略的發展至關重要，而獨特的區域特徵則造就了不同的推廣路徑。美洲地區擁有複雜的公私支付方組合、高密度的門診手術中心、臨床醫生在技術應用方面擁有高度自主權以及明確的報銷機制，這些因素都促進了成熟和新型外科手術解決方案的快速普及。

歐洲、中東和非洲的監管和報銷環境各不相同，這要求製造商採取區域性實證策略並儘早與支付方接洽。該區域內各國在卓越中心（COE）模式、醫院採購慣例和成本效益優先事項方面存在顯著差異，這會影響產品上市順序以及為支持更廣泛的市場准入而需要開展的上市後監測範圍。

亞太地區擁有廣泛的需求促進因素，包括新興經濟體人口老化、手術量增加、產能擴張等。各地區的生產和監管路徑，以及不同的臨床醫師訓練體系，都會影響新型微創技術融入常規診療的速度。在所有地區，分銷管道動態和關稅相關因素與當地監管壓力相互交織，共同決定產品的上市時間、定價策略以及與臨床醫生的合作計劃。

強調臨床證據、整合服務模式和供應鏈韌性的競爭策略如何重塑公司差異化和夥伴關係活動

青光眼手術器材領域的競爭體現在對產品改進、策略夥伴關係、實證醫學證據累積和臨床醫生培訓的投入。市場參與企業正致力於提升器械性能，以提高植入物的可重複性、耐用性和安全性，同時也在建構相關服務，以減輕手術團隊的營運負擔。

一些公司優先考慮整合價值提案，將器械供應與手術培訓、數位化支援工具和患者追蹤平台相結合，以展現實際療效和成本效益優勢。另一些公司則專注於地理擴張，透過加強與分銷商的關係或建立區域性生產來縮短前置作業時間並減輕關稅負擔。器械創新者與成熟的外科公司之間的合作日益普遍，這既能快速擴大市場覆蓋範圍，又能充分利用現有的銷售和培訓基礎設施。

這些措施的通用在於強調臨床證據和上市後監測，以增強支付方的參與度和臨床醫生的信心。那些將研發重點與明確的最終用戶需求（例如，醫院採購動態、門診手術中心的工作流程、眼科診所的限制）相結合的公司，往往能夠實現更連貫的市場推廣路徑。最終，競爭優勢不再僅取決於產品特性，還取決於能否提供可重複的臨床結果、簡化培訓流程以及確保供應鏈的可靠性。

對於製造商和相關人員，這是一個清晰、務實的策略舉措，有助於加強證據支持、提升供應鏈靈活性、建立差異化商業模式，並推動持久應用。

產業領導者應優先考慮一系列切實可行的舉措，以充分利用當前趨勢，同時降低營運和商業風險。首先，透過將臨床開發與真實世界證據的優先事項結合，加快支付方參與和臨床醫生採納。有針對性的臨床項目應重點關注對外科醫生和支付方都至關重要的安全性和生活品質終點。其次，透過生產和供應基地多元化，並儘可能採用近岸外包，可以減輕關稅引起的成本波動的影響，並提高對區域需求的應對力。

第三，製造商應投資量身定做的打入市場策略，以反映門診手術中心、醫院和眼科診所之間的差異，並針對每種環境調整培訓、報銷支援和服務模式。第四，銷售策略應有意採用混合模式：在專科中心建立強大的直銷關係，以增加接觸點；同時輔以數位通路和第三方經銷商，以擴大地域覆蓋範圍並提高效率。第五，企業應考慮透過將醫療設備與數位化追蹤工具和管理服務捆綁銷售來體現價值差異化，從而展現整體醫療成本效益。

最後，策略夥伴關係，例如共同開發、培訓網路和區域商業化，可以在共用實施風險的同時加快產品普及。透過實用化這些建議，產業領導者可以製定穩健的商業化計劃，使產品創新與實際應用路徑和支付方預期相契合。

嚴謹的混合方法研究設計，結合臨床醫師訪談、系統性文獻回顧和邏輯分析，將檢驗研究結果並找出限制。

本分析的調查方法融合了定性和定量方法，旨在確保其穩健性、偏好和對臨床醫生的相關性。主要研究包括對來自門診手術中心、醫院和眼科診所的外科醫生、採購負責人和臨床負責人進行結構化訪談，以了解他們的手術偏好、器械選擇標準和術後管理實踐。

二次研究包括對同行評審的臨床文獻、監管申報文件、器械標籤和行業出版刊物進行系統性回顧，以揭示雷射器械、分流器、支架和手術刀片的技術發展。透過交叉檢驗，結合主要受訪者的見解和二手訊息，對數據進行三角驗證，以減少偏差並識別一致的模式。應用分割映射法，將手術類別（例如傳統手術和微創手術）與器械原型和最終用戶行為相匹配。

分析方法包括對定性輸入資料進行主題綜合分析，以及對供應鏈和關稅影響進行情境分析。品管包括清晰記錄調查方法和資料來源，以確保調查方法的透明度。這種多層次的方法確保了結論既反映了前沿的臨床實踐，也反映了更廣泛的技術和政策促進因素。

簡明扼要地總結了流程演進、設備差異化和策略要務之間的關係，從而指明了產品推廣應用和永續商業性成功的路徑。

總之，青光眼手術器械領域是由臨床發展、技術差異化和商業性適應症三者之間複雜的相互作用所決定的。雖然傳統手術方法在治療晚期疾病方面仍然發揮著至關重要的作用，但微創手術正在再形成早期介入策略和手術全期管理。這些手術方式的演變也體現在器械的細分上，包括雷射器械、引流管、支架和手術刀片，每種器械都有其不同的臨床應用依據和推廣應用的挑戰。

區域和政策發展，包括與關稅相關的供應鏈調整，凸顯了製造彈性、分銷敏捷性和主導商業化的重要性。終端使用者——門診手術中心、醫院和眼科診所——正在尋求能夠滿足自身需求的合約模式，以反映其手術組合、採購週期和培訓需求。競爭優勢的差異化不僅取決於產品屬性，還取決於經實踐驗證的療效、可重複的植入技術以及綜合支援服務。

展望未來，能夠將有針對性的臨床證據產生、穩健的供應鏈策略和精細化的市場推廣執行相結合的相關人員，將更有能力把創新轉化為持續的臨床應用和商業性成功。這種整合為規劃後續步驟（包括產品開發、市場進入和組織投資）奠定了實際的基礎。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 微創青光眼手術植入（具有藥物釋放型功能，可降低眼內壓）的應用日益普及
  • 開發一種具有可調節管腔直徑的微型支架設計，用於個體化眼內壓管理
  • 整合即時術中影像導引系統，以提高手術精確度和安全性
  • 用於控制術後發炎的新型緩釋眼科藥物傳遞平台
  • 人們對用於遠端患者管理的遠端眼內壓監測植入越來越感興趣
  • 可生物分解的微創青光眼手術植入取得進展，可最大限度減少長期併發症
  • 醫療器材製造商與人工智慧公司合作，預測青光眼進展並最佳化手術時機
  • 加大對用於同時治療白內障和青光眼的聯合手術設備的投入
  • 新一代小梁網旁路植入物已獲得監管部門核准，植入具有更佳的生物相容性和長期通暢性

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 青光眼手術器械市場（依手術類型分類）

  • 傳統手術
    • 青光眼引流植入植入
    • 切除術
    • 分流管
  • 微創手術
    • IStent
    • 卡胡克雙刃
    • 橫紋肌瘤
    • XEN凝膠支架

9. 青光眼手術器械市場（依器械類型分類）

  • 雷射元件
    • 氬雷射器
    • 選擇性雷射
  • 分流
    • 艾哈邁德·巴爾布
    • 巴雷費爾特植入
    • 莫爾特諾植入
  • 支架
    • Hydrus 微支架
    • IStent
    • XEN凝膠支架
  • 手術刀片
    • 卡胡克雙刃
    • 曲安奈德裝置

第10章 青光眼手術器械市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 眼科診所

第11章 青光眼手術器械市場（依通路分類）

  • 直銷
  • 線上銷售
  • 第三方經銷商

12. 各地區青光眼手術器材市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 青光眼手術器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國青光眼手術器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Alcon Inc.
    • Bausch & Lomb Incorporated
    • AbbVie Inc.
    • Carl Zeiss Meditec AG
    • Santen Pharmaceutical Co., Ltd.
    • Glaukos Corporation
    • Nidek Co., Ltd.
    • Topcon Corporation
    • Ellex Medical Lasers Limited
    • New World Medical, Inc.
Product Code: MRR-A339DAEF9D8F

The Glaucoma Surgery Devices Market is projected to grow by USD 1,654.57 million at a CAGR of 7.23% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 945.93 million
Estimated Year [2025] USD 1,013.25 million
Forecast Year [2032] USD 1,654.57 million
CAGR (%) 7.23%

A focused introduction that frames clinical need, device typologies, care settings, and distribution pathways driving contemporary decision-making in glaucoma surgery devices

Glaucoma remains a leading cause of irreversible vision loss, and the clinical and commercial environment for surgical interventions has evolved rapidly in response to demographic pressures, regulatory developments, and technological advances. In this context, a concise introduction must frame the current landscape through the interplay of clinical need, device innovation, and evolving care pathways that influence clinician choice and patient outcomes.

Historically, conventional surgery approaches such as glaucoma drainage implants, trabeculectomy, and tube shunts have formed the backbone of surgical management for advanced disease, while microinvasive surgery options like iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent have expanded treatment options for earlier-stage disease and combined cataract-glaucoma procedures. These procedural distinctions are mirrored by device typologies that include laser devices subdivided into argon and selective laser modalities, shunts encompassing Ahmed valve, Baerveldt implant, and Molteno implant variants, stents such as Hydrus Microstent, iStent, and XEN Gel Stent, and surgical blades represented by Kahook Dual Blade and Trabectome platforms.

End-user dynamics also shape adoption patterns: ambulatory surgery centers, hospitals, and ophthalmic clinics each present different procedural volumes, reimbursement dynamics, and capital-acquisition models that influence procurement decisions. Distribution channels-including direct sales, online sales, and third-party distributors-further determine how devices reach clinicians and how manufacturers scale geographic coverage. Together, these elements establish the frame for readers to understand the subsequent sections, which examine transformative shifts, trade policy impacts, segmentation nuances, regional differentiators, competitive behaviors, and practical recommendations for industry leaders.

How clinical priorities, device innovation, and shifting procurement channels are converging to redefine treatment algorithms and commercial competition in glaucoma surgery

The landscape for glaucoma surgery devices is undergoing a series of transformative shifts that are redefining clinical algorithms, procurement practices, and innovation priorities. Clinically, there is a clear movement toward procedures that promise lower complication rates, faster recovery times, and compatibility with combined cataract procedures. As a result, clinicians are increasingly balancing the long-established efficacy of conventional surgery approaches such as glaucoma drainage implants, trabeculectomy, and tube shunts against the procedural simplicity and favorable perioperative profiles of microinvasive surgery options like iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent.

Technological advances are not limited to device miniaturization: laser technologies are differentiating into argon and selective modalities that target specific tissue interactions, while stent and shunt designs are iterating to improve biocompatibility, flow regulation, and implantation reproducibility. Device segmentation that includes laser devices, shunts, stents, and surgical blades is therefore shifting from discrete product families to integrated procedural ecosystems, where device choice is driven as much by system compatibility and surgeon preference as by clinical indication.

Meanwhile, delivery and commercialization models are evolving. Ambulatory surgery centers, hospitals, and ophthalmic clinics exhibit different incentive structures, influencing choice of direct sales relationships, online procurement options, or reliance on third-party distributors. Regulatory scrutiny and reimbursement policy adjustments are prompting manufacturers to prioritize evidence development and real-world outcomes, accelerating adoption pathways where clinical and economic value can be demonstrated. Taken together, these trends are creating a more pluralistic market environment in which multiple approaches coexist, competition is increasingly innovation-led, and market entry requires both clinical credibility and robust commercialization strategy.

The 2025 tariff-driven supply-chain recalibration and its operational, commercial, and procurement implications across manufacturing and distribution networks

The introduction of tariffs in 2025 introduced a new layer of complexity for global supply chains and pricing strategies for ophthalmic surgical devices. Manufacturers that source key components or finished devices from cross-border supply chains have faced increased input costs that, in many cases, require reassessment of manufacturing footprints, supplier contracts, and product pricing strategies. In response, some companies have accelerated localization of critical manufacturing steps or diversified suppliers to mitigate exposure, while others have absorbed incremental costs temporarily to preserve market access and clinician relationships.

These adjustments have had ripple effects across distribution channels and end users. Ambulatory surgery centers, hospitals, and ophthalmic clinics have experienced varying degrees of price sensitivity depending on their reimbursement environments and purchasing models. Where direct sales models predominate, manufacturers have worked closely with procurement teams to tailor pricing, bundling, or service agreements. Where third-party distribution remains important, distributors have had to renegotiate terms and manage inventory strategies to minimize margin compression.

Operationally, tariffs have encouraged a renewed focus on cost-to-serve analyses and total cost of ownership when evaluating devices. Manufacturers are placing higher emphasis on operational efficiency, supply-chain transparency, and post-market support that can justify price positions. At the same time, the policy environment has underscored the strategic importance of regional manufacturing capacities and flexible distribution networks to maintain resilience and responsiveness to clinician demand. Overall, the tariff-driven dynamics have accelerated pragmatic, near-term actions to stabilize supply, while prompting longer-term strategic shifts in where and how devices are produced and delivered.

A granular segmentation-driven perspective linking procedural types, device categories, care settings, and distribution channels to reveal targeted adoption pathways and positioning opportunities

Segmentation provides the scaffolding for nuanced analysis and market positioning, and a multifaceted segmentation approach reveals distinct growth levers and adoption barriers across procedure, device, end user, and distribution channels. Based on procedure, the market divides into conventional surgery and microinvasive surgery. Conventional surgery retains clinical primacy for advanced disease with established techniques such as glaucoma drainage implants, trabeculectomy, and tube shunts. Microinvasive surgery, which includes platforms such as iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent, is increasingly positioned for patients with mild to moderate disease or for combined cataract-glaucoma procedures because of favorable safety and recovery profiles.

From a device perspective, the landscape encompasses laser devices, shunts, stents, and surgical blades. Laser technologies bifurcate into argon and selective laser approaches that serve different tissue targets and procedural intents. Shunt solutions, including Ahmed valve, Baerveldt implant, and Molteno implant variants, continue to be central to management of refractory glaucoma. Stent technologies such as Hydrus Microstent, iStent, and XEN Gel Stent reflect innovation in minimally invasive outflow augmentation, while surgical blade systems like Kahook Dual Blade and Trabectome devices support tissue resection strategies with different learning curves and intraoperative profiles.

End-user segmentation highlights that ambulatory surgery centers, hospitals, and ophthalmic clinics each present unique adoption environments tied to case mix, capital planning cycles, and care delivery models. Distribution channel segmentation-direct sales, online sales, and third-party distributors-reveals how manufacturers must harmonize sales force strategies, digital channels, and distributor partnerships to ensure product availability, clinician training, and after-sales support. By mapping product innovation to these segmentation axes, stakeholders can identify where clinical needs align with commercial opportunity and where targeted evidence generation will most effectively drive adoption.

Regional strategic differentials across the Americas, Europe, Middle East & Africa, and Asia-Pacific that dictate tailored commercialization, evidence, and supply strategies

Regional dynamics are instrumental in shaping device strategy, reimbursement interactions, and commercialization tactics, and distinct regional characteristics create differentiated pathways to adoption. The Americas exhibit a complex mix of private and public payers, robust ambulatory surgery center activity, and a high degree of clinician autonomy in technology adoption, which together encourage rapid uptake of both established and novel surgical solutions where reimbursement clarity exists.

Europe, Middle East & Africa feature heterogeneous regulatory and reimbursement environments that compel manufacturers to adopt localized evidence strategies and engage payers early. Countries within this region vary considerably in their center-of-excellence models, hospital procurement practices, and emphasis on cost-effectiveness, which affects the sequencing of product launches and the scope of post-market studies required to support broader access.

Asia-Pacific presents a wide spectrum of demand drivers, from aging populations in developed economies to rising procedural volumes and capacity expansion in emerging markets. Local manufacturing and regulatory pathways, along with differing clinician training infrastructures, influence how quickly newer microinvasive technologies are integrated into standard practice. Across all regions, distribution channel dynamics and tariff-related considerations intersect with regional regulatory pressures to shape launch timing, pricing strategies, and clinician engagement plans.

How competitive strategies emphasizing clinical evidence, integrated service models, and supply-chain resilience are reshaping company differentiation and partnership activity

Competitive behavior among companies in the glaucoma surgery devices space reflects a mix of incremental product refinement, strategic partnerships, and investments in evidence generation and clinician training. Market participants are channeling resources toward device improvements that address implantation reproducibility, durability, and safety profiles, while simultaneously building services that reduce the operational burden on surgical teams.

Some firms are prioritizing integrated value propositions that combine device supply with procedural training, digital support tools, and patient follow-up platforms to demonstrate real-world outcomes and cost-to-serve advantages. Others are focusing on geographic expansion by strengthening distributor relationships or establishing regional manufacturing to reduce lead times and tariff exposure. Collaborations between device innovators and established surgical companies are becoming more common as a means to scale access quickly while leveraging established sales and training infrastructures.

Across these behaviors, the common thread is an emphasis on clinical evidence and post-market surveillance to support payer engagement and clinician confidence. Companies that align R&D priorities with clear end-user needs-hospital procurement dynamics, ambulatory surgery center workflows, or ophthalmic clinic constraints-tend to achieve more coherent adoption trajectories. Ultimately, competitive differentiation is increasingly defined by the ability to offer reproducible clinical outcomes, streamlined training, and supply-chain reliability rather than by product features alone.

Clear, practical strategic moves for manufacturers and stakeholders to strengthen evidence, supply agility, and differentiated commercial models that drive durable adoption

Industry leaders should prioritize a set of actionable initiatives to capitalize on current trends while mitigating operational and commercial risks. First, aligning clinical development with real-world evidence priorities will accelerate payer engagement and clinician uptake; targeted clinical programs should emphasize comparative safety and quality-of-life endpoints that matter to both surgeons and payers. Second, diversifying manufacturing and supplier bases-paired with nearshoring where feasible-will reduce exposure to tariff-driven cost volatility and improve responsiveness to regional demand.

Third, manufacturers should invest in tailored go-to-market strategies that reflect differences across ambulatory surgery centers, hospitals, and ophthalmic clinics, ensuring that training, reimbursement support, and service models are adapted to each setting. Fourth, distribution strategies must be deliberately hybrid: robust direct-sales relationships in high-touch specialty centers, complemented by digital channels and third-party distributors for broader geographic coverage and efficiency gains. Fifth, companies should consider bundling devices with digital follow-up tools or managed services to demonstrate total cost of care benefits and differentiate on value.

Finally, forging strategic partnerships-whether for co-development, training networks, or regional commercialization-can accelerate access while sharing implementation risk. By operationalizing these recommendations, industry leaders can build resilient commercialization plans that align product innovation with practical adoption pathways and payer expectations.

A rigorous mixed-methods research design combining clinician interviews, systematic literature review, and triangulated analysis to validate findings and highlight limitations

The research methodology underpinning this analysis integrates qualitative and quantitative approaches designed to ensure robustness, reliability, and practitioner relevance. Primary research included structured interviews with surgeons, procurement officers, and clinical leaders across ambulatory surgery centers, hospitals, and ophthalmic clinics to capture procedural preferences, device selection criteria, and post-operative management practices.

Secondary research involved systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and industry publications to contextualize technological developments across laser devices, shunts, stents, and surgical blades. Data were triangulated through cross-validation between primary respondent insights and secondary sources to reduce bias and identify consistent patterns. Segmentation mapping was applied to align procedural categories such as conventional surgery and microinvasive surgery with device archetypes and end-user behaviors.

Analytical techniques included thematic synthesis for qualitative inputs and scenario analysis for supply-chain and tariff impacts. Quality controls included respondent validation, where key findings were reviewed with a subset of interviewees for accuracy, and methodological transparency, with clear documentation of data sources, inclusion criteria, and any limitations. This layered approach ensured that conclusions reflect both frontline clinical practice and broader technology and policy dynamics.

A concise synthesis linking procedural evolution, device differentiation, and strategic imperatives that together define pathways to adoption and sustainable commercial success

In conclusion, the glaucoma surgery devices landscape is defined by a complex interplay of clinical evolution, technological differentiation, and commercial adaptation. Conventional surgical approaches maintain an indispensable role for advanced disease, while microinvasive options are reshaping earlier intervention strategies and perioperative management. These procedural dynamics are mirrored by device segmentation across laser devices, shunts, stents, and surgical blades, each with distinct clinical rationales and adoption challenges.

Regional and policy developments, including tariff-related supply-chain adjustments, have underscored the importance of manufacturing flexibility, distribution agility, and evidence-led commercialization. End users-ambulatory surgery centers, hospitals, and ophthalmic clinics-each demand tailored engagement models that reflect procedural mixes, procurement cycles, and training requirements. Competitive differentiation increasingly hinges on demonstrable real-world outcomes, reproducible implantation techniques, and integrated support services rather than product attributes alone.

Looking ahead, stakeholders that combine targeted clinical evidence generation, resilient supply-chain strategies, and nuanced go-to-market execution will be best positioned to convert innovation into sustained clinical adoption and commercial success. This synthesis provides a practical basis for planning next steps across product development, market entry, and organizational investments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of minimally invasive glaucoma surgery implants integrating drug-eluting capabilities to reduce intraocular pressure
  • 5.2. Development of micro-stent designs with adjustable lumen diameters for personalized intraocular pressure management
  • 5.3. Integration of real-time intraoperative imaging guidance systems to enhance surgical precision and safety
  • 5.4. Emergence of sustained release ocular drug delivery platforms for postoperative inflammation control
  • 5.5. Growing focus on telemetric intraocular pressure monitoring implants for remote patient management
  • 5.6. Advancements in biodegradable minimally invasive glaucoma surgery implants to minimize long-term complications
  • 5.7. Collaboration between device manufacturers and artificial intelligence firms to predict glaucoma progression and optimize surgical timing
  • 5.8. Increasing investment in combined cataract and glaucoma surgical devices for simultaneous dual pathology treatment
  • 5.9. Introduction of novel ab interno canaloplasty devices offering less invasive Schlemm's canal dilation without external incisions
  • 5.10. Regulatory approvals of next-generation trabecular meshwork bypass implants featuring enhanced biocompatibility and long-term patency

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glaucoma Surgery Devices Market, by Procedure

  • 8.1. Conventional Surgery
    • 8.1.1. Glaucoma Drainage Implants
    • 8.1.2. Trabeculectomy
    • 8.1.3. Tube Shunts
  • 8.2. Microinvasive Surgery
    • 8.2.1. IStent
    • 8.2.2. Kahook Dual Blade
    • 8.2.3. Trabectome
    • 8.2.4. XEN Gel Stent

9. Glaucoma Surgery Devices Market, by Device

  • 9.1. Laser Devices
    • 9.1.1. Argon Laser
    • 9.1.2. Selective Laser
  • 9.2. Shunts
    • 9.2.1. Ahmed Valve
    • 9.2.2. Baerveldt Implant
    • 9.2.3. Molteno Implant
  • 9.3. Stents
    • 9.3.1. Hydrus Microstent
    • 9.3.2. IStent
    • 9.3.3. XEN Gel Stent
  • 9.4. Surgical Blades
    • 9.4.1. Kahook Dual Blade
    • 9.4.2. Trabectome Device

10. Glaucoma Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
  • 10.3. Ophthalmic Clinics

11. Glaucoma Surgery Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
  • 11.3. Third Party Distributors

12. Glaucoma Surgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glaucoma Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glaucoma Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Alcon Inc.
    • 15.3.2. Bausch & Lomb Incorporated
    • 15.3.3. AbbVie Inc.
    • 15.3.4. Carl Zeiss Meditec AG
    • 15.3.5. Santen Pharmaceutical Co., Ltd.
    • 15.3.6. Glaukos Corporation
    • 15.3.7. Nidek Co., Ltd.
    • 15.3.8. Topcon Corporation
    • 15.3.9. Ellex Medical Lasers Limited
    • 15.3.10. New World Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE GLAUCOMA SURGERY DEVICES MAR